Phosphorus
Computational genomics company we want to create a world where every healthcare decision is optimized with genomics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Phosphorus operates in the genomics and health technology market, providing comprehensive genomic health solutions. The company offers insights into 447 genes that impact health and well-being, allowing individuals to take control of their health through personalized wellness guidance. Phosphorus also provides FDA-authorized at-home COVID-19 testing, making it convenient for users to get accurate viral testing from the comfort of their homes. The business model revolves around direct-to-consumer sales of genomic testing kits and health reports, as well as partnerships with healthcare providers. Revenue is generated through the sale of these kits and associated services. Phosphorus serves a diverse clientele, including individuals seeking to understand their genetic health, healthcare providers, and researchers. The company leverages advanced genomic technology to deliver actionable health insights, aiming to improve overall health outcomes.
Keywords: Genomic health, COVID-19 testing, personalized wellness, genetic insights, FDA-authorized, at-home testing, health technology, direct-to-consumer, healthcare providers, advanced genomics.